The abstract is read at the publisher; the summary is JClub's.
Intracoronary imaging–guided PCI in the drug-eluting stent era reduces target lesion failure versus angiography-guided PCI (RR 0.72, 95% CI 0.61–0.85).
- Why it matters: Guidelines support ICI-guided PCI for complex or left main disease, but newer trials have not shown clear benefit, leaving uncertainty about overall efficacy and why results differ.
- What they did: The authors searched RCTs through June 3, 2026 and meta-analyzed 28 trials (24,634 patients, mean follow-up 22 months) using direct and Bayesian methods, plus trial sequential, fragility, and meta-regression analyses.
- The result: ICI-guided PCI also reduced cardiac mortality (RR 0.73, 95% CI 0.58–0.91), myocardial infarction (RR 0.86, 0.75–0.97), target vessel revascularization (RR 0.69, 0.57–0.83), stent thrombosis (RR 0.55, 0.40–0.76), and all-cause mortality (RR 0.82, 0.70–0.96), with posterior probability >99% for benefit.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.